Taramasso, L., Tatarelli, P., Ricci, E., Madeddu, G., Menzaghi, B., Squillace, N., . . . Bonfanti, P. (2018). Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA). BMC Infect Dis.
استشهاد بنمط شيكاغوTaramasso, Lucia, et al. "Improvement of Lipid Profile After Switching From Efavirenz or Ritonavir-boosted Protease Inhibitors to Rilpivirine or Once-daily Integrase Inhibitors: Results From a Large Observational Cohort Study (SCOLTA)." BMC Infect Dis 2018.
MLA استشهادTaramasso, Lucia, et al. "Improvement of Lipid Profile After Switching From Efavirenz or Ritonavir-boosted Protease Inhibitors to Rilpivirine or Once-daily Integrase Inhibitors: Results From a Large Observational Cohort Study (SCOLTA)." BMC Infect Dis 2018.